Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001863013-21-000001
Filing Date
2021-06-02
Accepted
2021-06-02 12:56:42
Documents
1
Effectiveness Date
2021-06-02
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7116
  Complete submission text file 0001863013-21-000001.txt   8169
Mailing Address 12601 N. CAVE CREEK ROAD, SUITE 111 PHOENIX AZ 85022
Business Address 12601 N. CAVE CREEK ROAD, SUITE 111 PHOENIX AZ 85022 602-601-5293
Cellebration Life Sciences, Inc. (Filer) CIK: 0001863013 (see all company filings)

EIN.: 844791675 | State of Incorp.: WY | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-401437 | Film No.: 21988448